Alector LLC

Philip Ling Kong

Arnon Rosenthal

Tina Schwabe

Ilaria Tassi

Herve Rhinn

Angie Grace Yee

Muhammad Abbas Alhawagri

Seung-Joo Lee

Robert Pejchal

Eric Brown

Nels P Nielson

Jeonghoon Sun

Wei-Hsien Ho

Hua Long

Ananya Mitra

Daniel P Bermingham

Francesca Cignarella

Klaus-Dieter Heger

Karpagam Srinivasan

Santiago Viveros Salazar

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-MS4A4A antibodies and methods of use thereof

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A6A polypeptide, e g., a mammalian MS4A6A or human MS4A6A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-MS4A6A antibodies and methods of use thereof

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, humanized antibodies and antibody fragments, that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 or human TREM2, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-TREM2 antibodies and methods of use thereof

Growing community of inventors

San Francisco, CA, United States of America

Philip Ling Kong